Previous close | 3.7000 |
Open | 3.9000 |
Bid | 1.8000 |
Ask | 3.1000 |
Strike | 400.00 |
Expiry date | 2024-06-21 |
Day's range | 2.9000 - 3.9000 |
Contract range | N/A |
Volume | |
Open interest | 159 |
Financial Performance Aligns with Analyst Projections Despite Revenue Dip
CRISPR Therapeutics (CRSP) reports mixed earnings results for first-quarter 2024. Management claims that the commercial launch for the first ever CRISPR-based gene therapy is progressing well.
As you might know, Vertex Pharmaceuticals Incorporated ( NASDAQ:VRTX ) just kicked off its latest quarterly results...